Clinical Trials Office 9310 Campus Point Drive Modular B La Jolla, CA USA
Phone
:
858-657-6776
Fax
:
858.657.7025
E-mail
:
null
Website
:
null
Treatment
:
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303